{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:06:16Z","timestamp":1770959176069,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Fund","award":["81573778"],"award-info":[{"award-number":["81573778"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07404-6","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T03:01:45Z","timestamp":1710730905000},"page":"2153-2165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of pregnancy outcomes in women with normal ovarian response to the gonadotropin-releasing hormone agonist protocol using different trigger methods: a single-center retrospective cohort study based on propensity score matching"],"prefix":"10.1007","volume":"309","author":[{"given":"Danyang","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"issue":"4","key":"7404_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmv016","volume":"21","author":"MC Inhorn","year":"2015","unstructured":"Inhorn MC, Patrizio P (2015) Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 21(4):411\u201326. https:\/\/doi.org\/10.1093\/humupd\/dmv016","journal-title":"Hum Reprod Update."},{"issue":"10178","key":"7404_CR2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(18)32843-5","volume":"393","author":"D Wei","year":"2019","unstructured":"Wei D, Liu JY, Sun Y et al (2019) Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet 393(10178):1310\u20131318. https:\/\/doi.org\/10.1016\/S0140-6736(18)32843-5","journal-title":"Lancet"},{"issue":"11","key":"7404_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.605939","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Su R, Wu Y (2021) Cumulative live birth rate and cost-effectiveness analysis of gonadotropin releasing hormone-antagonist protocol and multiple minimal ovarian stimulation in poor responders. Front Endocrinol (Lausanne) 14(11):605939. https:\/\/doi.org\/10.3389\/fendo.2020.605939","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"7404_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/s0015-0282(03)00173-0","volume":"79","author":"M Ludwig","year":"2003","unstructured":"Ludwig M, Doody KJ, Doody KM (2003) Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril 79(5):1051\u20131059. https:\/\/doi.org\/10.1016\/s0015-0282(03)00173-0","journal-title":"Fertil Steril"},{"issue":"4","key":"7404_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s13224-016-0952-5","volume":"67","author":"SA Hebisha","year":"2017","unstructured":"Hebisha SA, Aboelazm BA, Sallam HN (2017) GnRH antagonist cetrorelix administration before hCG for protection of ovarian hyperstimulation syndrome. J Obstet Gynaecol India 67(4):270\u2013274. https:\/\/doi.org\/10.1007\/s13224-016-0952-5","journal-title":"J Obstet Gynaecol India"},{"issue":"7","key":"7404_CR6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","volume":"35","author":"J Haas","year":"2020","unstructured":"Haas J, Bassil R, Samara N et al (2020) GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Hum Reprod 35(7):1648\u20131654. https:\/\/doi.org\/10.1093\/humrep\/deaa107","journal-title":"Hum Reprod"},{"issue":"03","key":"7404_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.fertnstert.2016.06.002","volume":"106","author":"J Haas","year":"2016","unstructured":"Haas J, Ophir L, Barzilay E et al (2016) Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study. Fertil Steril 106(03):653\u2013659. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.06.002","journal-title":"Fertil Steril"},{"issue":"9","key":"7404_CR8","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10815-021-02226-w","volume":"38","author":"N Gonen","year":"2021","unstructured":"Gonen N, Casper RF, Jurisicova A et al (2021) Does gonadotropin-releasing hormone agonist cause luteolysis by inducing apoptosis of the human granulosa-luteal cells? J Assist Reprod Genet 38(9):2301\u20132305. https:\/\/doi.org\/10.1007\/s10815-021-02226-w","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"7404_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5812\/ijem.5034","volume":"11","author":"P Alama","year":"2013","unstructured":"Alama P, Bellver J, Vidal C, Giles J (2013) GnRH analogues in the prevention of ovarian hyperstimulation syndrome. Int J Endocrinol Metab 11(2):107\u201316. https:\/\/doi.org\/10.5812\/ijem.5034","journal-title":"Int J Endocrinol Metab"},{"issue":"1","key":"7404_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00404-019-05163-3","volume":"300","author":"C Zeng","year":"2019","unstructured":"Zeng C, Shang J, Jin AM et al (2019) The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study. Arch Gynecol Obstet 300(1):223\u2013233. https:\/\/doi.org\/10.1007\/s00404-019-05163-3","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"7404_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12884-022-04499-0","volume":"22","author":"Y He","year":"2022","unstructured":"He Y, Tang Y, Chen S et al (2022) Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study. BMC Pregnancy Childbirth 22(1):172. https:\/\/doi.org\/10.1186\/s12884-022-04499-0","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"7404_CR12","first-page":"429","volume":"15","author":"M Eftekhar","year":"2017","unstructured":"Eftekhar M, Mojtahedi MF, Miraj S et al (2017) Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: an RCT. Int J Reprod Biomed 15(7):429\u2013434","journal-title":"Int J Reprod Biomed"},{"issue":"8","key":"7404_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","volume":"21","author":"R Orvieto","year":"2015","unstructured":"Orvieto R (2015) Triggering final follicular maturation\u2013hCG, GnRH-agonist or both, when and to whom? J Ovarian Res 21(8):60. https:\/\/doi.org\/10.1186\/s13048-015-0187-6","journal-title":"J Ovarian Res"},{"issue":"8","key":"7404_CR14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/humrep\/deac114","volume":"37","author":"C Zhou","year":"2022","unstructured":"Zhou C, Yang X, Wang Y et al (2022) Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles. Hum Reprod 37(8):1795\u20131805. https:\/\/doi.org\/10.1093\/humrep\/deac114","journal-title":"Hum Reprod"},{"issue":"7","key":"7404_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09513590.2019.1576621","volume":"35","author":"J Haas","year":"2019","unstructured":"Haas J, Zilberberg E, Nahum R et al (2019) Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study Gynecol Endocrinol 35(7):628\u2013630. https:\/\/doi.org\/10.1080\/09513590.2019.1576621","journal-title":"A pilot study Gynecol Endocrinol"},{"issue":"3","key":"7404_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.xfre.2021.05.008","volume":"2","author":"RK Chung","year":"2021","unstructured":"Chung RK, Mancuso AC, Summers KM et al (2021) Dual trigger protocol is an effective in vitro fertilization strategy in both normal and high responders without compromising pregnancy outcomes in fresh cycles. F S Rep 2(3):314\u2013319. https:\/\/doi.org\/10.1016\/j.xfre.2021.05.008","journal-title":"F S Rep"},{"issue":"2","key":"7404_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","volume":"100","author":"SL Broer","year":"2013","unstructured":"Broer SL, D\u00f3lleman M, van Disseldorp J et al (2013) Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril 100(2):420-429.e7. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.04.024","journal-title":"Fertil Steril"},{"issue":"7","key":"7404_CR18","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC et al (2011) ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26(7):1616\u20131624. https:\/\/doi.org\/10.1093\/humrep\/der092","journal-title":"Hum Reprod"},{"key":"7404_CR19","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome(PCOS) Hum Reprod 19(1): 41\u201347","DOI":"10.1093\/humrep\/deh098"},{"issue":"3","key":"7404_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.rbmo.2012.10.021","volume":"26","author":"C Racowsky","year":"2013","unstructured":"Racowsky C, Machtinger R (2013) Morphological systems of human embryo assessment and clinical evidence. Reprod Biomed Online 26(3):210\u2013221. https:\/\/doi.org\/10.1016\/j.rbmo.2012.10.021","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"7404_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/s0015-0282(99)00311-8","volume":"72","author":"WB Schoolcraft","year":"1999","unstructured":"Schoolcraft WB, Gardner DK, Lane M et al (1999) Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril 72(4):604\u2013609. https:\/\/doi.org\/10.1016\/s0015-0282(99)00311-8","journal-title":"Fertil Steril"},{"issue":"4","key":"7404_CR22","first-page":"203","volume":"6","author":"W Decleer","year":"2014","unstructured":"Decleer W, Osmanagaoglu K, Seynhave B et al (2014) Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial. Facts Views Vis Obgyn 6(4):203\u2013209","journal-title":"Facts Views Vis Obgyn"},{"issue":"02","key":"7404_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/09513590.2014.978850","volume":"31","author":"E Zilberberg","year":"2015","unstructured":"Zilberberg E, Haas J, Dar S et al (2015) Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecol Endocrinol 31(02):145\u2013147. https:\/\/doi.org\/10.3109\/09513590.2014.978850","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"7404_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1757-2215-7-77","volume":"2","author":"J Haas","year":"2014","unstructured":"Haas J, Zilberberg E, Dar S et al (2014) Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles\u2013a preliminary report. J Ovarian Res 2(7):77","journal-title":"J Ovarian Res"},{"issue":"3","key":"7404_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.mefs.2018.01.001","volume":"23","author":"A Alleyassin","year":"2018","unstructured":"Alleyassin A, Ghasemi M, Aghahosseini M et al (2018) Final oocyte maturation with a dual trigger compared to human chorionic gonadotropin trigger in antagonist co-treated cycles: a randomized clinical trial. Middle East Fertil Soc J 23(3):199\u2013204. https:\/\/doi.org\/10.1016\/j.mefs.2018.01.001","journal-title":"Middle East Fertil Soc J"},{"issue":"3","key":"7404_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ijgo.13405","volume":"152","author":"AM Maged","year":"2021","unstructured":"Maged AM, Ragab MA, Shohayeb A et al (2021) Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: a randomized controlled study. Int J Gynaecol Obstet 152(3):395\u2013400. https:\/\/doi.org\/10.1002\/ijgo.13405. (Epub 2020 Oct 22)","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"7404_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.fertnstert.2007.06.030","volume":"90","author":"BS Shapiro","year":"2008","unstructured":"Shapiro BS, Daneshmand ST, Garner FC et al (2008) Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril 90(1):231\u2013233. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.06.030. (Epub 2007 Nov 5)","journal-title":"Fertil Steril"},{"issue":"6","key":"7404_CR28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","volume":"97","author":"D Griffin","year":"2012","unstructured":"Griffin D, Benadiva C, Kummer N et al (2012) Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril 97(6):1316\u20131320. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.03.015. (Epub 2012 Apr 3)","journal-title":"Fertil Steril"},{"issue":"1","key":"7404_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00404-018-4751-3","volume":"298","author":"C Chen","year":"2018","unstructured":"Chen C, Tzeng C, Wang P et al (2018) Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF\/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis. Arch Gynecol Obstet 298(1):17\u201326. https:\/\/doi.org\/10.1007\/s00404-018-4751-3","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"7404_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5935\/1518-0557.20210039","volume":"26","author":"S Albeitawi","year":"2022","unstructured":"Albeitawi S, Marar EA, Reshoud FA et al (2022) Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles. JBRA Assist Reprod 26(1):28\u201332. https:\/\/doi.org\/10.5935\/1518-0557.20210039","journal-title":"JBRA Assist Reprod"},{"issue":"5","key":"7404_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/humrep\/des037","volume":"27","author":"R Beck-Fruchter","year":"2012","unstructured":"Beck-Fruchter R, Weiss A, Lavee M et al (2012) Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Hum Reprod 27(5):1357\u20131367","journal-title":"Hum Reprod"},{"issue":"6","key":"7404_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10815-017-0917-3","volume":"34","author":"RT Elias","year":"2017","unstructured":"Elias RT, Pereira N, Artusa L et al (2017) Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization. J Assist Reprod Genet 34(6):781\u2013788. https:\/\/doi.org\/10.1007\/s10815-017-0917-3. (Epub 2017 Apr 13)","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"7404_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","volume":"104","author":"VL Baker","year":"2015","unstructured":"Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ (2015) Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 104(5):1145\u201352. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.07.1151. (Epub 2015 Aug 18)","journal-title":"Fertil Steril."},{"issue":"8","key":"7404_CR34","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s43032-022-00954-7","volume":"29","author":"C Demirel","year":"2022","unstructured":"Demirel C, Celik HG, Tulek F et al (2022) Dual trigger with hCG plus GnRHa for final oocyte maturation in PGT-A cycles results in similar euploidy rates when compared to hCG-Only trigger. Reprod Sci 29(8):2265\u20132271. https:\/\/doi.org\/10.1007\/s43032-022-00954-7","journal-title":"Reprod Sci"},{"issue":"7","key":"7404_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235707","volume":"15","author":"CU Chern","year":"2020","unstructured":"Chern CU, Li JY, Tsui KH et al (2020) Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: a retrospective cohort study. PLoS ONE 15(7):e0235707. https:\/\/doi.org\/10.1371\/journal.pone.0235707","journal-title":"PLoS ONE"},{"issue":"9","key":"7404_CR36","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"NG Beckers","year":"2003","unstructured":"Beckers NG, Macklon NS, Eijkemans MJ et al (2003) Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88(9):4186\u20134192. https:\/\/doi.org\/10.1210\/jc.2002-021953","journal-title":"J Clin Endocrinol Metab"},{"key":"7404_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejogrb.2017.09.004","volume":"218","author":"N Ding","year":"2017","unstructured":"Ding N, Liu X, Jian Q et al (2017) Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 218:92\u201398. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.09.004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"7404_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/09513590.2016.1193141","volume":"32","author":"M Kasum","year":"2016","unstructured":"Kasum M, Kurdija K, Ore\u0161kovi\u0107 S et al (2016) Combined ovulation triggering with GnRH agonist and hCG in IVF patients. Gynecol Endocrinol 32(11):861\u2013865. https:\/\/doi.org\/10.1080\/09513590.2016.1193141","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"7404_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046682","volume":"7","author":"L Casarini","year":"2012","unstructured":"Casarini L, Lispi M, Longobardi S et al (2012) LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS ONE 7(10):e46682. https:\/\/doi.org\/10.1371\/journal.pone.0046682. (Epub 2012 Oct 5)","journal-title":"PLoS ONE"},{"issue":"1","key":"7404_CR40","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12958-022-01017-x","volume":"20","author":"Y Yung","year":"2022","unstructured":"Yung Y, Aizer A, Tieb S et al (2022) The in-vitro effect of gonadotropins\u2019 type and combination on granulosa cells gene expressions. Reprod Biol Endocrinol 20(1):144. https:\/\/doi.org\/10.1186\/s12958-022-01017-x","journal-title":"Reprod Biol Endocrinol"},{"key":"7404_CR41","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.fertnstert.2011.01.019","volume":"95","author":"JD Lamb","year":"2011","unstructured":"Lamb JD, Shen S, McCulloch C et al (2011) Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial. Fertil Steril 95:1655\u20131660. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.01.019","journal-title":"Fertil Steril"},{"issue":"1","key":"7404_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/humupd\/dmz037","volume":"26","author":"Y Mizrachi","year":"2020","unstructured":"Mizrachi Y, Horowitz E, Farhi J et al (2020) Ovarian stimulation for freeze-all IVF cycles: a systematic review. Hum Reprod Update 26(1):118\u2013135. https:\/\/doi.org\/10.1093\/humupd\/dmz037","journal-title":"Hum Reprod Update"},{"issue":"2","key":"7404_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10815-021-02359-y","volume":"39","author":"H Ganer Herman","year":"2022","unstructured":"Ganer Herman H, Horowitz E, Mizrachi Y et al (2022) Prediction, assessment, and management of suboptimal GnRH agonist trigger: a systematic review. J Assist Reprod Genet 39(2):291\u2013303. https:\/\/doi.org\/10.1007\/s10815-021-02359-y","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"7404_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fendo.2019.00639","volume":"18","author":"A Benmachiche","year":"2019","unstructured":"Benmachiche A, Benbouhedja S, Zoghmar A et al (2019) Low LH level on the day of GnRH agonist trigger is associated with reduced ongoing pregnancy and live birth rates and increased early miscarriage rates following IVF\/ICSI treatment and fresh embryo transfer. Front Endocrinol (Lausanne) 18(10):639. https:\/\/doi.org\/10.3389\/fendo.2019.00639","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7404_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000490946","volume":"84","author":"R Beck-Fruchter","year":"2019","unstructured":"Beck-Fruchter R, Baram S, Geslevich Y et al (2019) Gonadotropin releasing hormone agonist final oocyte maturation and human chorionic gonadotropin as exclusive luteal support in normal responders. Gynecol Obstet Invest 84(1):27\u201334. https:\/\/doi.org\/10.1159\/000490946","journal-title":"Gynecol Obstet Invest"},{"key":"7404_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12688\/f1000research.17036.1","volume":"8","author":"B Wiweko","year":"2019","unstructured":"Wiweko B, Satria ML, Mutia K et al (2019) Correlation between luteinizing hormone receptor gene expression in human granulosa cells with oocyte quality in poor responder patients undergoing in vitro fertilization: a cross\u2013sectional study. F1000Res 8:16. https:\/\/doi.org\/10.12688\/f1000research.17036.1","journal-title":"F1000Res"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07404-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:10:09Z","timestamp":1713157809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07404-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["7404"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07404-6","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients had signed written informed consent for assisted reproductive technology. The study was retrospective and did not require ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}